| |
 |
Details: |
 |
|
|
Develops and commercializes innovative products for the treatment of melanoma, prostate cancer, viral diseases, including HIV infection. Information for investors, and details of the company in Tarrytown, New York. (Nasdaq: PGNX).
|
| URL: |
http://www.progenics.com/
|
| Title: |
Progenics Pharmaceuticals, Inc. |
| Image: |
 |
| Description: |
Business, Biotechnology and Pharmaceuticals, Pharmaceuticals, Biopharmaceuticals - Progenics Pharmaceuticals Inc.. Develops and commercializes innovative products for the treatment of melanoma, prostate cancer, viral diseases, including HIV infection. |
| Similar: |
|
|
|
Related Sites |
|
Pharmos Corporation (Popularity:  ): Develops and commercializes products for the central nervous system (CNS), neurological, ophthalmic and other healthcare markets.
ConjuChem, Inc. (Popularity: ): Focuses on the application of its bioconjugation platform in various therapeutic areas such as cancer, pain, HIV, diabetes and thrombosis. ...
Connetics Corporation (Popularity: ): Principally engaged in rapid commercialization of new therapies in the areas of rheumatology and dermatology. Includes product pipeline, investor relations, ...
Generex Biotechnology (Popularity: ): Developed a proprietary technology to orally administer large molecule drugs. These drugs include proteins, peptides, monoclonal antibodies, hormones and vaccines.
Genfit (Popularity: ): Researching nuclear receptors and gene deregulation for treatment of cardiovascular, metabolic and inflammatory diseases. Includes information about genomic research.
Lybradyn: Microbial Natural Products (Popularity: ): Focused on discovering and developing natural products from living organisms to serve the pharmaceutical and fine chemical industries. Includes explanation ...
Morphochem (Popularity: ): Focuses on finding therapeutic agents to treat diseases. Particular emphasis is on protein to protein interactions.
Modular Genetics, Inc. (Popularity: ): Supporting basic research, drug design, drug screening and chemical synthesis.
Myogen, Inc. (Popularity: ): Develops therapeutic drugs to treat heart failure using expertise in molecular cardiology and a human heart tissue bank. Includes product ...
Virax Holdings, Ltd. (Popularity: ): Developing therapeutics for autoimmune diseases, AIDS, cancers, infectious diseases based on patented Co-X-Gene platform technology co-expressing antibodies and T cells. ...
Nymox Pharmaceutical Corp. (Popularity: ): Researches and develops neurological diagnostics and pharmaceuticals for the aging population with emphasis on alzheimer's disease. Comprehensive profile of company ...
Repligen Corporation (Popularity: ): Researches, develops, manufactures and markets synthetic version of protein A for monoclonal antibody processing, and peptides such as secretin for ...
|
|
Popular Sites |
|
African Reptiles and Venom (Popularity: ): Supplier of snake venom for anti-serum production, with captive reptile breeding for pet trade. Offer film work, field tours, courses ...
Aphios Corp. (Popularity: ): Developing natural therapeutics, with a focus on infectious diseases, cancer and quality-of-life medicines. Overview of extraction and nanoscale technologies, product ...
Bavarian Nordic (Popularity: ): Developer and manufacturer offering prevention and treatment of infectious diseases, with pre-clinical research programs, and has established products for HIV ...
Genfit (Popularity: ): Researching nuclear receptors and gene deregulation for treatment of cardiovascular, metabolic and inflammatory diseases. Includes information about genomic research.
BioMarin Pharmaceutical Inc. (Popularity: ): Researches and develops therapies for debilitating, fatal, chronic genetic disorders causing enzyme deficiency of carbohydrate metabolism, such as phenylketonuria. Headquarters ...
|
|
Related Press |
|
Great Lakes Pharmaceuticals, Inc., Announces $2.4 Million Equity Financing (Popularity: ): Great Lakes Pharmaceuticals, Inc. announced today the completion of Series A $2.4 million equity financing led by Ohio investment funds ...
Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease (Popularity: ): Iodine has been used as an antimicrobial for the last century. Much has been written about molecular iodine yet many ...
Watson' Launches Generic Kadian(R) (Popularity: ): PARSIPPANY, N.J., Nov. 10, 2011 -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that it has received approval from the ...
Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis (Popularity: ): Cerimon Pharmaceuticals, Inc., announced today it has initiated a Phase II proof-of-concept study of Simulect(R) (basiliximab) for the treatment of ...
DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease (Popularity: ): Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing anti-inflammatory drugs, announced today that after completing its review of safety ...
|
|
Related Articles |
|
|
|
|
